307 related articles for article (PubMed ID: 36511181)
1. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD009650. PubMed ID: 36511181
[TBL] [Abstract][Full Text] [Related]
2. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009650. PubMed ID: 30030966
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
[TBL] [Abstract][Full Text] [Related]
4. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Hurley MN; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2013 Feb; (2):CD009650. PubMed ID: 23450608
[TBL] [Abstract][Full Text] [Related]
5. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
Lo DK; Hurley MN; Muhlebach MS; Smyth AR
Cochrane Database Syst Rev; 2015 Feb; (2):CD009650. PubMed ID: 25927091
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
9. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Southern KW; Solis-Moya A; Kurz D; Smith S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
[TBL] [Abstract][Full Text] [Related]
10. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
[TBL] [Abstract][Full Text] [Related]
11. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
[TBL] [Abstract][Full Text] [Related]
12. Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.
Dawson S; Girling CJ; Cowap L; Clark-Carter D
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013766. PubMed ID: 36989170
[TBL] [Abstract][Full Text] [Related]
13. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright CE; Smyth AR
Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
[TBL] [Abstract][Full Text] [Related]
14. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
[TBL] [Abstract][Full Text] [Related]
15. Exercise versus airway clearance techniques for people with cystic fibrosis.
Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
[TBL] [Abstract][Full Text] [Related]
16. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM; Smith S
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001506. PubMed ID: 37319354
[TBL] [Abstract][Full Text] [Related]
17. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
[TBL] [Abstract][Full Text] [Related]
18. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
[TBL] [Abstract][Full Text] [Related]
19. Appetite stimulants for people with cystic fibrosis.
McTavish D; Thornton J
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD008190. PubMed ID: 36149378
[TBL] [Abstract][Full Text] [Related]
20. Short-acting inhaled bronchodilators for cystic fibrosis.
Smith S; Rowbotham NJ; Edwards CT
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013666. PubMed ID: 35749226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
